Cargando…

Healthcare Resource Utilization and Costs for Empagliflozin Versus Glucagon-Like Peptide-1 Receptor Agonists in Routine Clinical Care in Denmark

INTRODUCTION: The sodium-glucose cotransporter 2 inhibitor (SGLT2i) empagliflozin has shown reductions in major adverse cardiac events similar to glucagon-like peptide-1 receptor agonists (GLP-1RAs). However, evidence is limited about how these therapies compare regarding overall healthcare resource...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomsen, Reimar W., Christensen, Lotte W. B., Kahlert, Johnny, Knudsen, Jakob S., Ustyugova, Anastasia, Sandgaard, Susanne, Holmgaard, Pia, Ehlers, Lars H., Sørensen, Henrik T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663772/ https://www.ncbi.nlm.nih.gov/pubmed/36315384 http://dx.doi.org/10.1007/s13300-022-01323-y

Ejemplares similares

Cardiovascular Events, Acute Hospitalizations, and Mortality in Patients With Type 2 Diabetes Mellitus Who Initiate Empagliflozin Versus Liraglutide: A Comparative Effectiveness Study
por: Thomsen, Reimar W., et al.
Publicado: (2021)

The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark
por: Ehlers, Lars H., et al.
Publicado: (2022)

The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease
por: Ehlers, Lars Holger, et al.
Publicado: (2021)

Changes in SGLT2i and GLP-1RA real-world initiator profiles following cardiovascular outcome trials: A Danish nationwide population-based study
por: Knudsen, Jakob S., et al.
Publicado: (2020)

Nationwide trends in glucose-lowering drug use, Denmark, 1999–2014
por: Christensen, Diana Hedevang, et al.
Publicado: (2016)

Hospitalization for hypoglycaemia in people with diabetes in Denmark, 1997–2017: Time trends in incidence and HbA(1c) and glucose‐lowering drug use before and after hypoglycaemia
por: Bengtsen, Mads Bisgaard, et al.
Publicado: (2021)

Long‐acting glucagon‐like peptide‐1 receptor agonists have direct access to and effects on pro‐opiomelanocortin/cocaine‐ and amphetamine‐stimulated transcript neurons in the mouse hypothalamus
por: Knudsen, Lotte Bjerre, et al.
Publicado: (2016)

Decreasing trends, and geographical variation in outpatient antibiotic use: a population-based study in Central Denmark
por: Kristensen, Pia Kjær, et al.
Publicado: (2019)

Validation of algorithms to detect distant metastases in men with prostate cancer using routine registry data in Denmark
por: Ehrenstein, Vera, et al.
Publicado: (2015)

Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period
por: Levison, Lotte Sahin, et al.
Publicado: (2019)

Association of pneumococcal conjugate vaccination with rates of ventilation tube insertion in Denmark: population-based register study
por: Groth, Christina, et al.
Publicado: (2015)

Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study
por: Kristensen, Frederik Pagh Bredahl, et al.
Publicado: (2023)

Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China
por: Ramos, Mafalda, et al.
Publicado: (2021)

Development of a 5-year risk prediction model for type 2 diabetes in individuals with incident HbA1c-defined pre-diabetes in Denmark
por: Nicolaisen, Sia K, et al.
Publicado: (2022)

Hospital-based herpes zoster diagnoses in Denmark: rate, patient characteristics, and all-cause mortality
por: Schmidt, Sigrun A. J., et al.
Publicado: (2016)

Diabetes, glycemic control and risk of medical glaucoma treatment: A population-based case-control study
por: Welinder, Lotte G, et al.
Publicado: (2009)

Validity of asthma diagnoses and patterns of anti‐asthmatic drug use in a cohort of 2053 Danish children
por: Rubak, Sune, et al.
Publicado: (2018)

Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: A Danish 24-year population-based study
por: Knudsen, Jakob S., et al.
Publicado: (2022)

Existing data sources for clinical epidemiology: The clinical laboratory information system (LABKA) research database at Aarhus University, Denmark
por: Grann, Anne Fia, et al.
Publicado: (2011)

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
por: Vilsbøll, Tina, et al.
Publicado: (2012)

Cohort profile: the Funen Diabetes Database—a population-based cohort of patients with diabetes in Denmark
por: Adelborg, Kasper, et al.
Publicado: (2020)

Evaluation of commercially available glucagon receptor antibodies and glucagon receptor expression
por: Bomholt, Anna Billeschou, et al.
Publicado: (2022)

Association of common comorbidities with osteonecrosis: a nationwide population-based case–control study in Denmark
por: Dima, Alina, et al.
Publicado: (2018)

Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease
por: Ramos, Mafalda, et al.
Publicado: (2019)

Association of α1-Blocker Receipt With 30-Day Mortality and Risk of Intensive Care Unit Admission Among Adults Hospitalized With Influenza or Pneumonia in Denmark
por: Thomsen, Reimar W., et al.
Publicado: (2021)

Short-term mortality after perforated or bleeding peptic ulcer among elderly patients: a population-based cohort study
por: Christensen, Steffen, et al.
Publicado: (2007)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018)

Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UK
por: Ramos, Mafalda, et al.
Publicado: (2020)

Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons
por: Balijepalli, Chakrapani, et al.
Publicado: (2018)

The molecular pharmacology of glucagon agonists in diabetes and obesity
por: Novikoff, Aaron, et al.
Publicado: (2023)

Using registries to identify type 2 diabetes patients
por: Thomsen, Reimar W, et al.
Publicado: (2014)

Disentangling the complexity of mobility of older medical patients in routine practice: An ethnographic study in Denmark
por: Kirk, Jeanette Wassar, et al.
Publicado: (2019)

Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
por: Underwood, Christina Rye, et al.
Publicado: (2010)

Real‐world use of cardioprotective glucose‐lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019
por: Funck, Kristian L., et al.
Publicado: (2020)

Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease
por: Reifsnider, Odette S, et al.
Publicado: (2021)

Trends in Hysterectomy Incidence Rates During 2000–2015 in Denmark: Shifting from Abdominal to Minimally Invasive Surgical Procedures
por: Lycke, Kathrine Dyhr, et al.
Publicado: (2021)

Rationale and design of the EMPERIAL‐Preserved and EMPERIAL‐Reduced trials of empagliflozin in patients with chronic heart failure
por: Abraham, William T., et al.
Publicado: (2019)

Healthcare resource utilization in patients treated with empagliflozin in East Asia
por: Sheu, Wayne H‐H, et al.
Publicado: (2022)

The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care
por: Patorno, Elisabetta, et al.
Publicado: (2019)

Body Mass Index of 92,027 patients acutely admitted to general hospitals in Denmark: Associated clinical characteristics and 30-day mortality
por: Gribsholt, Sigrid Bjerge, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mhnn5i28enr8rp3qjoigkshhl3